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strains. We report the results of a genotyping study based on microsatellite markers of Candida albicans (n = 179) and Candida parapsilosis
(n = 76) causing candidaemia, to assess and compare the percentage of patients grouped in clusters during the study period (January 2010 to
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with Candida albicans and Candida parapsilosis being the most
common entities in most geographical areas [1]. Exogenous
strains of C. albicans and C. parapsilosis can infect patients
admitted to hospital and cause outbreaks of candidaemia [2].
Highly discriminatory genotyping procedures are useful when
investigating the genetic relationships between isolates [2]. The
presence of clusters (identical genotypes infecting different
patients) suggests patient-to-patient transmission or a common
source for strains. We previously observed that up to 11% of
C. albicans genotypes and 18% of C. parapsilosis genotypesClin Microbiol Infect 2015; 21: 677–683
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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Hospital in Madrid (Spain) were clusters [3,4]. These data
suggest highly effective transmission of strains in hospitals.
However, it is unknown whether this percentage is similar to
that found in other large hospitals.
We report the results of a genotyping study based on mi-
crosatellite markers of C. albicans and C. parapsilosis causing
candidaemia in patients admitted to two large tertiary hospitals
in Madrid, Spain that aimed to assess and compare the per-
centage of patients grouped in clusters in the centres over a
speciﬁc period. We also included isolates collected at a third
hospital in Rome, Italy, to study the presence of genotypes
clustering in a non-geographically related institution.Materials and methodsHospital description and collection of isolates
Gregorio Marañon (Hospital A) serves a population of
approximately 715 000 inhabitants, and Ramón y Cajal (Hos-
pital B) serves a population of approximately 600 000 in-
habitants. Both hospitals care for all types of patients at risk of
acquiring candidaemia, including patients with haematological
malignancies, solid organ transplant recipients, patients with
central venous catheters, patients admitted to medical and
surgical intensive care units, and neonates (only Hospital A).
The distance between the hospitals is 11 km.
During the study period (January 2010 to December 2012), a
total of 230 and 123 episodes of candidaemia were recorded in
patients admitted to Hospital A and Hospital B, respectively.
One isolate per patient was studied (incident isolate). The
number of C. albicans and C. parapsilosis isolates included in each
centre is shown in Table 1.
In both hospitals, blood samples were obtained for culture
using standard procedures and incubated in the automatedTABLE 1. Number of Candida albicans and Candida parapsilosis iso
clusters and patients in cluster are also shown
Candida albicans
Hospital A Hospital B O
Number of isolates 116 63 1
Mean number of alleles 21.7 16.0 2
Observed heterozygositya 0.664 0.612 0
Expected heterozygositya 0.804 0.768 0
Wright’s indexb 0.155 0.191 0
Probability of identityc 7.98 × 10−9 7.19 × 10−8 1
Number of genotypes 101 49 1
No. of clusters (%) 9 (9%) 10 (20.4%) 2
No. of patients in cluster (%) 24 (20.7)% 24 (38.1%) 5
Diversity parameters calculated are shown by each species and per hospital. Mean number o
Numbers in bold indicate signiﬁcant differences.
aObserved and expected heterozygosities ranged from 0 (no heterozygosity) to 1 (highest h
bWright’s index indicates a deﬁciency of heterozygosity (positive values) or excess heterozy
cTotal probability of identity indicates the probability of ﬁnding two identical genotypes afte
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectBactec 9240 (from 2010) and Bactec™-FX system (2011–2012)
(Becton-Dickinson, Cockeysville, MD, USA).
Blood cultures with presumptive visualization of yeasts in the
Gram stain were subcultured on CHROMagar (CHROMagar,
Paris, France) in Hospital A, and on CandiSelect agar (BioRad,
Marnes La Coquette, France) in Hospital B. Plates were incu-
bated for 24–48 h at 35–37°C. Presumptive identiﬁcation was
conﬁrmed by internal transcribed spacer sequencing (Hospital
A) [5] and by matrix-assisted laser desorption/ionization time of
ﬂight mass spectrometry on a Microﬂex LT (Daltonik, Bremen,
Germany) (Hospital B) [6].
Genotyping procedure
Genotyping was based on microsatellite markers. The micro-
satellite markers used for C. albicans were CDC3, EF3 and HIS3
[7,8] and CAI, CAIII and CAVI [9]. The microsatellite markers
used for C. parapsilosis were CP1, CP4a, CP6, and B, as previ-
ously described [10,11]. Capillary electrophoresis was carried
out in a 3130xl analyser, and data were analysed using Gene-
Mapper 4.0 software (Applied Biosystems-Life Technologies
Corporation, Foster City, CA, USA).
Genetic diversity analysis
The allelic composition was studied for each locus, as C. albicans
and C. parapsilosis are diploid and can be homozygous or het-
erozygous for each marker. The parameters of genetic diversity
studied for each locus were calculated as previously reported
[3,4]. The number of alleles per locus observed heterozygosity
(Ho) (direct count calculated as the number of heterozygous
genotypes over the total number of genotypes analysed for
each locus); expected heterozygosity (He) (where He = 1 −
Σpi2, where pi is the frequency of the ith allele) [12]; Wright’s
ﬁxation index (F = 1 − (Ho/He)), which shows the relationships
between Ho and He and detects an excess or deﬁciency of
heterozygotes [13]; and, ﬁnally, the probability of identity forlates studied; the number of genotypes and the percentage of
Candida parapsilosis
verall Hospital A Hospital B Overall
79 46 30 76
2 17.8 12.0 20.25
.644 0.525 0.408 0.48
.797 0.842 0.768 0.825
.192 0.366 0.458 0.418
.30 × 10−8 1.19 × 10−6 2.16 × 10−5 2.31 × 10−6
45 42 22 63
1 (14.4%) 3 (7.1%) 4 (18.1%) 7 (11.1%)
3 (29.6%) 7 (14.9%) 12 (40%) 20 (26.3%)
f alleles, and the observed and expected heterozygosity are shown as mean per locus.
eterozygosity).
gosity (negative values).
r randomly selecting two isolates.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 677–683
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are the frequencies of the ith and jth alleles, respectively), which
measures the probability that two randomly drawn diploid ge-
notypes will be identical, assuming observed allele frequencies
and random assortment [14].
Genotyping results were converted to binary data by scoring
the presence or absence of each allele. Data were treated as
categorical, and the genetic relationship between all the geno-
types found was studied by constructing a minimum spanning
tree (BioNumerics version 6.6; Applied Maths, Sint-Martens-
Latem, Belgium). Isolates were considered to have identical
genotypes when they showed the same alleles for all loci;
identical genotypes were conﬁrmed. A cluster was deﬁned as
the same genotype infecting two or more patients. We
compared the number of clusters and the percentage of pa-
tients in the clusters found in Hospital A and Hospital B using
the chi-square test. We also included isolates causing candi-
daemia (C. albicans, n = 89; C. parapsilosis, n = 46) in patients
admitted to Policlinico Universitario Agostino Gemelli, Rome,
Italy during the study period to study the presence of isolates
clustering in a non-geographically related hospital.ResultsAnalysis of genetic diversity
We studied the C. albicans and C. parapsilosis isolates from the
two hospitals to analyse genetic diversity parameters (Fig. 1a,b).
The diversity of the C. albicans isolates was as follows:
number of alleles, 132 (mean 22 alleles per locus); observed and
expected heterozygosity, 0.64 and 0.79; and probability of
identity, 1.3 × 10−8. The diversity of the C. parapsilosis isolates
was as follows: number of alleles, 81 (mean 20.25 alleles per
locus); observed and expected heterozygosity, 0.48 and 0.83;
and probability of identity, 2.31 × 10−6. The parameters for
each hospital are shown in Table 1.
Of the 145 C. albicans genotypes found, 21 were in clusters
(Fig. 1a). We also found 63 C. parapsilosis genotypes, seven of
which were in clusters (Fig. 1b). Clusters involved two to seven
patients each (Tables 2 and 3).
Analysis of clusters
The number of genotypes found, the number of clusters, and
the percentage of patients in clusters are shown in Table 1.
Nine and ten C. albicans clusters were found in Hospital A
and Hospital B, respectively; however, the percentage of pa-
tients in each cluster was higher in Hospital B (38.1%) than in
Hospital A (20.7%) (p < 0.05) (Table 1). In the case of
C. parapsilosis, three and four clusters were found in Hospital A
and Hospital B, respectively; similarly, the proportion ofClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologypatients in each cluster was higher in Hospital B (40%) than in
Hospital A (15%) (p < 0.05) (Table 1). Considering both spe-
cies, 19.1% and 38% of patients admitted to Hospital A and
Hospital B, respectively, were in clusters (p < 0.05). Tables 2
and 3 and Fig. 1 summarize data for the patients involved in
the clusters. Patients in the cluster infected by C. albicans were
not generally admitted to the same unit, with the exception of
three clusters in the neonatology ward of Hospital A (CA-34,
CA-227 and CA-371) and four clusters found in the oncology,
internal medicine, haematology and intensive care departments
of Hospital B (CA-100, CA-230, CA-290 and CA-303) (Table 2
and Fig. 1a). In contrast, no clusters of patients admitted to the
same wards and infected by C. parapsilosis were found in Hos-
pital A, but in hospital B, two clusters were found in patients
admitted to the general intensive care unit (CP-31 and CP-70)
(Table 3 and Fig. 1b).
Some strains clustered in patients admitted to Hospitals A
and B (C. albicans (genotypes CA-48, CA-59, CA-63, CA-165
and CA-310); C. parapsilosis (genotype CP-117)) (Tables 2
and 3). Up to 8.2% were infected by the genotypes found in
Hospitals A and B, and up to 2.9% of genotypes were present in
both hospitals. We also studied the presence of genotypes
clustering in patients admitted to Hospital A, Hospital B and
Policlinico Universitario Agostino Gemelli in Rome. Six geno-
types were found in the hospital in Rome and in Hospital A
(CP23 and CP-111), in Hospital B (CA-71, CA-100, CA-159),
or in all three hospitals (CA-165).DiscussionOur study shows that the number of patients grouped in
clusters differed between the two hospitals; the highest number
of patients per cluster was found in hospital B. This percentage
was higher for both C. albicans and C. parapsilosis and suggests
different rates of strain transmission in each hospital.
The study of the genetic diversity of Candida isolates causing
candidaemia provides information on the distribution of geno-
types within the hospital and can reveal the presence of clus-
ters. Microsatellite markers have high discriminatory power and
reproducibility and are useful for studying the genetic diversity
of Candida spp. [2].
We previously observed a high number of C. albicans-infec-
ted patients in clusters admitted to Hospital A [4]. In the pre-
sent study, we describe the genetic diversity of C. albicans and
C. parapsilosis isolates from patients with candidaemia admitted
to two tertiary hospitals in Madrid as well as genotypes clus-
tering in both hospitals and a hospital in Rome. Genetic di-
versity between C. albicans and C. parapsilosis differed, probably
owing to the different number of isolates studied. The overalland Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 677–683
Genotypes from patients admitted to Hospital A  
Genotypes from patients admitted to Hospital B 
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TABLE 2. Clusters of Candida albicans found in Hospitals A and B
Genotype code
Allelic composition (bp)
No. of patients
involved
Ward of admission
at the time of blood
sample collection Hospital
Date of blood culture
collection (month/day/year)CDC3 EF3 HIS3 CAI CAIII CAVI
CA-34 120–124 143–148 149–191 203–216 92–92 234–273 3 Neonatology A 8/2/10
12/10/10
12/16/10
CA-50 116–128 146–146 154–154 206–228 95–95 239–239 3 Angiology A 7/17/10
Neonatology 11/23/10
12/16/10
CA-51 116–128 135–146 154–154 206–228 95–95 239–239 4 Paediatrics A 4/30/10
Oncology 7/15/10
Geriatric 12/18/10
General Surgery 8/23/11
CA-56 116–116 135–146 154–154 206–206 95–95 239–239 2 Reanimation 3/1/10
Neonatology 1/6/12
CA-64 116–128 135–149 154–154 206–228 95–95 239–239 2 Infectious diseases A 7/13/10
Oncology 1/2/12
CA-227 116–116 125–134 162–162 234–293 95–109 246–246 2 Neonatology A 3/2/10
4/15/10
CA-343 116–124 130–130 162–195 216–228 95–98 246–276 3 Angiology A 7/7/10
Internal Medicine 4/20/11
CA-371 116–124 130–130 166–195 216–228 95–98 251–276 4 Neonatology A 9/21/10
9/24/10
10/5/10
10/24/10
CA-4 124–124 130–138 199–221 228–231 104–104 280–299 2 Haematology B 4/6/11
Intensive care unit (ICU) 6/9/11
CA-71 116–128 135–146 154–154 228–228 95–95 239–239 2 Urology B 3/9/11
ICU 9/15/10
CA-303 116–124 130–130 162–187 216–231 95–98 246–269 2 ICU B 1/7/11
12/28/11
CA-290 116–124 125–134 162–221 304–307 95–115 246–246 2 Haematology B 9/3/12
9/5/12
CA-230 116–124 125–134 162–162 234–298 95–95 246–246 2 Internal Medicine B 9/12/12
9/10/12
CA-223 116–124 134–134 162–203 249–287 109–109 246–284 2 General Surgery B 7/9/12
Oncology 7/15/12
CA-366 116–124 130–130 183–195 216–228 95–98 265–276 2 Urology B 12/26/11
ICU 11/23/10
CA-100 116–124 128–143 154–154 185–185 92–95 239–262 2 Oncology B 11/10/10
11/11/10
CA-59 116–116 135–146 154–154 206–228 95–95 239–239 4 Urology A 2/2/10
Neurology 11/29/12
Paediatrics B 3/7/12
ICU 11/20/12
CA-310 116–124 130–130 162–187 228–228 95–98 246–269 2 General Surgery A 2/25/10
Oncology B 11/10/10
CA-63 116–128 135–135 154–154 206–228 95–95 239–239 2 ICU A 1/25/11
B 9/9/10
CA-165 112–116 129–135 149–162 231–255 92–95 234–246 2 Internal Medicine A 5/12/10
ICU B 6/8/10
CA-48 116–128 135–146 154–154 206–206 95–95 239–239 7 Neonatology A 8/5/12
Internal Medicine B 9/3/12
9/10/12
Digestive 5/31/12
6/5/12
Urology 11/9/10
General Surgery 11/29/10
CMI Marcos-Zambrano et al. Candida clusters causing candidaemia 681genetic diversity found in both species did not differ much from
that found in each centre.
We found that the number of patients per cluster differed
signiﬁcantly depending on the centre. The differences in the
percentage of patients per cluster between Hospital A and
Hospital B also suggest different rates of strain transmission;FIG. 1. Minimum spanning tree indicating the Candida albicans genotypes (a)
genotypes found (circles). The number of patients in each cluster is indicated
colour of the circle (green circles, Hospital A; brown circles, Hospital B). Conn
solid line indicates differences in only one marker, a solid line indicates differe
and short dashes indicate differences in four or more markers. Genotypes in cl
by the number of the cluster. Circles in bold indicate genotypes also found i
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyalthough we did not investigate the reasons for this observation,
it could be a consequence of differences in catheter care, or the
type of patients admitted to each hospital.
We found that up to 2.9% of genotypes were present in the
two hospitals in Madrid; some genotypes were also found in the
hospital in Rome. Genotypes clustering in different hospitalsand Candida parapsilosis genotypes (b). The ﬁgure shows the different
by the size of the circles; the hospital of admission is indicated by the
ecting lines between circles show the similarity between proﬁles: a bold
nces in two markers, long dashes indicate differences in three markers,
usters are labelled CA (i.e. C. albicans) or CP (i.e. C. parapsilosis) followed
n Hospital Policlinico Universitario Agostino Gemelli, Rome, Italy.
and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 677–683
TABLE 3. Clusters of Candida parapsilosis found in Hospitals A and B
Genotype code
Microsatellite fragments (bp)
No. of patients
involved
Ward of admission
at the time of blood
sample collection Hospital
Date of blood culture collection
(month/day/year)CP1 CP4a CP6 B
CP-145 242–242 256–256 254–267 145–145 2 Emergency A 5/7/10
Oncology 8/21/10
CP-63 245–245 291–24 267–269 113–129 2 Neonatology A 8/30/10
Oncology 8/6/11
CP-31 224–245 300–300 317–317 129–129 2 Intensive care unit (ICU) B 12/12/11
11/14/11
CP-70 245–245 303–303 286–286 127–129 2 ICU B 7/31/11
8/1/11
CP-87 245–245 325–342 317–317 127–127 4 Oncology B 7/19/11
7/17/11
Otolaryngology 7/14/11
ICU 9/28/11
CP-138 208–242 240–240 312–321 133–133 4 ICU B 2/24/10
Internal Medicine 7/8/11
3/2/11
Infectious diseases 12/21/11
CP-117 239–245 240–240 265–265 133–133 4 Angiology A 10/19/10
General surgery 4/30/11
ICU A 11/30/11
B 9/12/10
The genotype code, the allelic composition, the number of patients involved, the wards of admission of the patients at the time of diagnosis, and date of the blood culture collection
are shown for each cluster.
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[15–17] or even in different countries [18]. However, these
studies are limited by the use of less discriminative typing
procedures, analysis of mainly C. albicans isolates, and the study
of isolates recovered from the intensive care unit. The high
percentage of genotypes found in more than one centre is
difﬁcult to explain, and different hypotheses could be proposed.
First, certain genotypes may be predominant in the population
or in the environment, as previously reported with Staphylo-
coccus aureus, or so-called bacterial high-risk strains could adapt
well to the hospital environment [19]. Second, the possible
absence of a sexual cycle means that some clones could expand
in the environment. Finally, microsatellite markers are limited
owing to homoplasy (alleles with identical size but different
sequences) or sexual recombination that can lead to strains
with the same genotype but a different epidemiological source
[15,20]. Next-generation sequencing analysis may help to
identify various genotypes with the same microsatellite proﬁle.
Our study is subject to a series of limitations. First, it was not
designed to prove nosocomial transmission, because we did not
include environmental isolates or isolates from the hands of the
healthcare workers to trace an epidemiological link. Finally, the
presence of genotypes clustering different hospitals should be
proved through highly discriminatory approaches such as whole
genome sequencing.
In conclusion, C. albicans and C. parapsilosis clusters causing
candidaemia differed between hospitals, suggesting differences
in strain transmission. Furthermore, some genotypes can be
found in patients admitted to hospitals located in different cities.
Genotyping should be performed to evaluate the impact of
campaigns to decrease patient-to-patient Candida transmission
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